Cash And Equivalent Veränderung Datum
Acadia Pharmaceuticals USD 188.66M 90.46M 2023-12
Agios Pharmaceuticals USD 88.2M 23.87M 2023-12
Akebia Therapeutics USD 42.92M 3.6M 2023-12
ALKERMES USD 647.71M 18.08M 2023-09
Alnylam Pharmaceuticals USD 812.69M 220.34M 2023-12
Amgen USD 10.94B 23.8B 2023-12
Biogen USD 1.05B 1.24B 2023-12
BioMarin Pharmaceutical USD 755.13M 30.29M 2023-12
Bluebird Bio USD 165.35M 7.52M 2023-09
Exelixis USD 396.86M 67.62M 2023-09
Immunic USD 59.69M 17.6M 2023-09
Incyte USD 3.21B 13.85M 2023-12
Intra Cellular Therapies USD 147.77M 48.36M 2023-12
Ionis Pharmaceuticals USD 399.27M 47.21M 2023-12
Nektar Therapeutics USD 64.92M 14.19M 2023-09
Neurocrine Biosciences USD 293.7M 133.5M 2023-09
Regeneron Pharmaceuticals USD 16.24B 14.09B 2023-12
Ultragenyx Pharmaceutical USD 777.11M 704.54M 2023-12
Vertex Pharmaceuticals USD 11.11B 959.1M 2023-09



Prothena Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.